Mostrar el registro sencillo del ítem
dc.contributor.author | Otero Vegas, Larissa | |
dc.contributor.author | De Orbegoso, A. | |
dc.contributor.author | Navarro, A. F. | |
dc.contributor.author | Ríos, J. | |
dc.contributor.author | Párraga, T. | |
dc.contributor.author | Gotuzzo Herencia, José Eduardo | |
dc.contributor.author | Seas Ramos, Carlos Rafael | |
dc.contributor.author | Van der Stuyft, P. | |
dc.date.accessioned | 2019-02-06T14:57:42Z | |
dc.date.available | 2019-02-06T14:57:42Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/5499 | |
dc.description.abstract | OBJECTIVE: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. METHODS: We studied new smear-positive TB adults that were started on MDR TB treatment or that were switched to it between June 2008 and December 2011. RESULTS: Time from the first positive smear to MDR-TB treatment was >30 days in 35% (13/37) of patients. Among the 27% (24/88) of patients that switched to MDR-TB treatment, time from the last dose of a drug-susceptible regimen was >30 days. CONCLUSION: Start of and switching to MDR TB treatment is still delayed. | en_US |
dc.language.iso | eng | |
dc.publisher | Wiley | |
dc.relation.ispartofseries | Tropical Medicine and International Health | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Peru | en_US |
dc.subject | Adult | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Retrospective Studies | en_US |
dc.subject | Tuberculosis | en_US |
dc.subject | Time Factors | en_US |
dc.subject | Peru/epidemiology | en_US |
dc.subject | tuberculosis | en_US |
dc.subject | tuberculose | en_US |
dc.subject | Outcome Assessment (Health Care) | en_US |
dc.subject | Incidence | en_US |
dc.subject | Antitubercular Agents/therapeutic use | en_US |
dc.subject | Drug Substitution/statistics & numerical data | en_US |
dc.subject | multidrug resistant | en_US |
dc.subject | multiresistante | en_US |
dc.subject | multirresistente | en_US |
dc.subject | Perou | en_US |
dc.subject | temps jusqu'au traitement | en_US |
dc.subject | Tiempo hasta el inicio del tratamiento | en_US |
dc.subject | time to treatment | en_US |
dc.subject | Tuberculosis, Multidrug-Resistant/drug therapy/epidemiology | en_US |
dc.subject | Tuberculosis, Pulmonary/drug therapy/epidemiology | en_US |
dc.title | Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1111/tmi.12430 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.06 | |
dc.relation.issn | 1365-3156 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |